Latest News

Opinion: Covid-19 has exposed the limits of the pharmaceutical market model

That so much hope is being pinned on remdesivir, the drug Gilead is testing for Covid-19, reflects the failure of our system for new drug development rather than the unqualified success some commentators are making it out to be.

If anything, remdesivir is the poster child for why we need a new model of drug development for pandemics and neglected diseases that isn’t restricted by the current market-based model.

Read the rest…

Source link

Related posts

Dangers Of Noise: Negative Effects Of Loud Sounds To Health Revealed


Malaria expert warns of need for malaria drug to treat severe cases in US


STAT Plus: Blackstone Group invests up to $2 billion in Alnylam, a big bet on the Cambridge biotech


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World